Tag: AMGN

Some of this year’s best performers in the healthcare sector are companies expected to profit from the anti-obesity drug craze, ...

Amgen has a couple of shots on goal to break into one of the biggest markets the pharmaceutical industry has ...

Pentwater Capital predicted that FTC efforts to block big deals would fail.

Wall Street should pay attention as the pharma industry mounts a widening legal campaign against the Inflation Reduction Act.

Coherus BioSciences’ partnership to offer deeply discounted biosimilar Humira can go only so far in reducing overall prices.

A number of thematic funds are focused on companies that help seniors who want to stay in their homes as ...

The drugmaker recently had a market value almost $18 billion as big pharmaceutical companies rely on acquisitions to expand sales.

MarketsHeard on the StreetAs AbbVie’s Humira faces copycat biologics, the biggest beneficiaries will be the middlemen negotiating and dispensing the ...

U.S. stock indexes pared losses after being on course for a fifth consecutive down day as investors weighed interest rates ...